1. Mudde ACA, Lexmond WS, Blumberg RS, Nurko S, Fiebiger E. Eosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental models. World Allergy Organ J. 2016;9:23.
2. Guarino MP, Cicala M, Behar J. Eosinophilic esophagitis: new insights in pathogenesis and therapy. World J Gastrointest Pharmacol Therapeut. 2016;7(1):66–77.
3. Choudhury S, Baker S. Eosinophilic esophagitis: the potential role of biologics in its treatment. Clin Rev Allergy Immunol. 2019.
4. Gisasola P, Iriarte A, Larez MR, Casanova L, Bujanda L. Mediastinal abscess, an unusual way of presentation of eosinophilic esophagitis. Allergy Asthma Clin Immunol. 2019;15:12.
5. Andreae DA, Hanna MG, Magid MS, Malerba S, Andreae MH, Bagiella E, et al. Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis. Am J Gastroenterol. 2016;111(8):1187–97.